Laurence Rodriguez
Vorstandsvorsitzender bei GENSIGHT BIOLOGICS S.A.
Profil
Laurence Rodriguez is currently the Chief Executive Officer & Director at Gensight Biologics SA. Previously, she worked as the Head of Rare Diseases & Rare Blood Disorders at Genzyme Therapeutics Ltd.
Ms. Rodriguez completed her undergraduate and graduate degrees at Sciences Po.
Aktive Positionen von Laurence Rodriguez
Unternehmen | Position | Beginn |
---|---|---|
GENSIGHT BIOLOGICS S.A. | Vorstandsvorsitzender | 21.12.2023 |
Ehemalige bekannte Positionen von Laurence Rodriguez
Unternehmen | Position | Ende |
---|---|---|
Genzyme Therapeutics Ltd.
Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Genzyme Therapeutics Ltd. develops transformative therapies for patients affected by rare and debilitating diseases. Its treatment areas include thyroid cancer, sclerosis, Fabry disease and Pompe. The company was founded on November 5, 2001 and is headquartered in Oxford, the United Kingdom. | Corporate Officer/Principal | - |
Ausbildung von Laurence Rodriguez
Sciences Po | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
GENSIGHT BIOLOGICS S.A. | Health Technology |
Private Unternehmen | 1 |
---|---|
Genzyme Therapeutics Ltd.
Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Genzyme Therapeutics Ltd. develops transformative therapies for patients affected by rare and debilitating diseases. Its treatment areas include thyroid cancer, sclerosis, Fabry disease and Pompe. The company was founded on November 5, 2001 and is headquartered in Oxford, the United Kingdom. | Health Technology |